BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8949824)

  • 41. The neuromuscular effects of mivacurium in adults with priming technique during nitrous oxide-fentanyl anesthesia: a randomized comparative study with succinylcholine.
    Lin SM; Chu YC; Lur JY; Lin SH; Hsiao HT; Lee TY; Tsai SK
    Acta Anaesthesiol Sin; 1998 Jun; 36(2):75-80. PubMed ID: 9816716
    [TBL] [Abstract][Full Text] [Related]  

  • 42. H1 and H2 blockade: a prophylactic principle in anesthesia and surgery against histamine-release responses of any degree of severity: Part 1.
    Lorenz W; Doenicke A
    N Engl Reg Allergy Proc; 1985; 6(1):37-57. PubMed ID: 2442588
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuromuscular and cardiovascular effects of mivacurium chloride in surgical patients receiving nitrous oxide-narcotic or nitrous oxide-isoflurane anaesthesia.
    Choi WW; Mehta MP; Murray DJ; Sokoll MD; Forbes RB; Gergis SD; Abou-Donia M; Kirchner J
    Can J Anaesth; 1989 Nov; 36(6):641-50. PubMed ID: 2573436
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Speed and ease of tracheal intubation: priming with mivacurium compared with succinylcholine.
    Molbegott L; Baker T
    Can J Anaesth; 1995 Sep; 42(9):780-4. PubMed ID: 7497557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mivacurium chloride (BW B1090U)-induced neuromuscular blockade during nitrous oxide-isoflurane and nitrous oxide-narcotic anesthesia in adult surgical patients.
    Weber S; Brandom BW; Powers DM; Sarner JB; Woelfel SK; Cook DR; Foster VJ; McNulty BF; Weakly JN
    Anesth Analg; 1988 Jun; 67(6):495-9. PubMed ID: 2967644
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium.
    Miller DR; Bryson G; Martineau RJ; Kitts JB; Curran M; Bragg P; Watson JB; Hull K; Lindsay P
    Can J Anaesth; 1995 Nov; 42(11):996-1002. PubMed ID: 8590511
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic carbamazepine therapy does not influence mivacurium-induced neuromuscular block.
    Spacek A; Neiger FX; Spiss CK; Kress HG
    Br J Anaesth; 1996 Oct; 77(4):500-2. PubMed ID: 8942336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuromuscular and cardiovascular effects of mivacurium chloride (BW B109OU) during nitrous oxide-narcotic, nitrous oxide-halothane and nitrous oxide-isoflurane anesthesia in surgical patients.
    Pearson KS; From RP; Choi WW; Abou-Donia M; Sokoll MD
    Middle East J Anaesthesiol; 1990 Jun; 10(5):469-78. PubMed ID: 2146482
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inflammatory skin responses induced by icatibant injection are mast cell mediated and attenuated by H(1)-antihistamines.
    Maurer M; Church MK
    Exp Dermatol; 2012 Feb; 21(2):154-5. PubMed ID: 22142018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacodynamics of mivacurium in children, using a computer-controlled infusion.
    Meretoja OA; Olkkola KT
    Br J Anaesth; 1993 Aug; 71(2):232-7. PubMed ID: 8123398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [New muscle relaxants].
    Diefenbach C; Buzello W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Feb; 31(1):2-8. PubMed ID: 8868525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of cholinesterase activity on pharmacodynamics of mivacurium preceded by pancuronium in elderly and young adults.
    Osman ES; Khafagy HF; Radwan KG; Desouky AM
    J Egypt Soc Parasitol; 2007 Apr; 37(1):243-55. PubMed ID: 17580581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mivacurium and bronchospasm.
    Bishop MJ; O'Donnell JT; Salemi JR
    Anesth Analg; 2003 Aug; 97(2):484-485. PubMed ID: 12873940
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prolonged mivacurium-induced neuromuscular block. Case report.
    Arcioni R; Sanfilippo M; Romano R; Lappa A; Mercieri M; Müller TM; Marcotullio D
    Minerva Anestesiol; 1999 Oct; 65(10):737-9; discussion 740. PubMed ID: 10598432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prophylactic administration of histamine 1 and/or histamine 2 receptor blockers in the prevention of heparin- and protamine-related haemodynamic effects.
    Kanbak M; Kahraman S; Celebioglu B; Akpolat N; Ercan S; Erdem K
    Anaesth Intensive Care; 1996 Oct; 24(5):559-63. PubMed ID: 8909666
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human.
    Naclerio RM; Kagey-Sobotka A; Lichtenstein LM; Freidhoff L; Proud D
    Am Rev Respir Dis; 1990 Jul; 142(1):167-71. PubMed ID: 1695070
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rocuronium- and mivacurium-induced neuromuscular block and intubating conditions: a comparison with vecuronium.
    van den Broek L; Hommes FD; Nap HJ; Wierda JM
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():27-30. PubMed ID: 8557002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of suxamethonium and different combinations of rocuronium and mivacurium for rapid tracheal intubation in children.
    Naguib M; Samarkandi AH; Ammar A; Turkistani A
    Br J Anaesth; 1997 Oct; 79(4):450-5. PubMed ID: 9389261
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Atracurium besylate (Tracrium)--a new nondepolarizing muscle relaxant].
    Agoston S; Langrehr D
    Anaesthesist; 1984 Nov; 33(11):539-42. PubMed ID: 6083733
    [No Abstract]   [Full Text] [Related]  

  • 60. Premedication with H1 and H2 blocking agents reduces the incidence of postoperative nausea and vomiting.
    Doenicke AW; Hoernecke R; Celik I
    Inflamm Res; 2004 Aug; 53 Suppl 2():S154-8. PubMed ID: 15338068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.